Philanthropic Partnership Backs Country-Led Research to Guide the Use of AI in Health
The Novo Nordisk Foundation, Gates Foundation, and Wellcome will support locally led evaluations of AI tools that have the potential to improve health outcomes in low- and middle-income countries
The first call for proposals, now open, focuses on mature AI tools that support decision-making in primary and community health settings
New Delhi, India, 20 February 2026 – The Novo Nordisk Foundation, Gates Foundation, and Wellcome today announced a joint investment of US$60 million to support locally led evaluations of AI health tools in low- and middle-income countries (LMICs). The Evidence for AI in Health (EVAH) initiative will help governments and health systems determine which tools work, where they add value, and how they can be used responsibly.
